Search results for "bispecific"

Article Updating Viral Clearance for New Biologic Modalities
“The industry has a way to go in developing a range of viral clearance products that enable efficient separation of more complex mAbs, such as bispecific or Fc-fusion proteins,” he says. Another c…

Article Advancements in Antibody Purification
Learn more and register here >>  The demand for more efficient and agile downstream purification processes for diversified therapeutic antibody pipelines requires the development of new…

Article Meeting the Process Development Challenges of a Diverse Biologic Pipeline
Click here to read more >> Understanding the challenges novel and diverse biological molecules can create and how to manage these challenges is key to ensuring they reach patients safely and eff…

Article Technology Innovations Improve Process Chromatography Performance
Bispecific antibodies, antibody-drug conjugates, engineered glycovariants, fusion proteins—all these molecules need to be purified with a templated approach using resins with a predictable behavior,” …

Article Improving Upstream Predictability
Better understanding and control of cell behavior is yielding benefits, upstream and beyond. By Agnes Shanley In the earliest days of biotech, developers often struggled to sust…

Article 2019’s Top Bioprocessing Trends and What to Expect in 2020
Speaking of purification, new types of molecules such as bispecific antibodies (BsAbs) have also created issues in this area. Bioprocess Development Forum provided insights into “navigating the jungle…

Article Optimizing Drug Safety and Efficacy of Complex Next-Generation Biologics
In recent years, the global biopharma industry has seen a rapidly advancing trend toward biotherapeutics or ‘biologic’ drugs—drugs that are produced from living organisms or contain components of li…

Article Scaling Up Novel Therapies
In addition, he says, it will speed up and allow for screening of a much larger number of variants for mAbs, bispecifics, trispecfics, fragments, and recombinant proteins. For some cell therapies, the…

Article Process Development: What May Lie Ahead in 2018?
Such next-gen antibodies include antibody drug conjugates, engineered antibodies, bispecific antibodies, antibody fragments, antibody-like proteins and biosimilar antibody therapies. The productio…

Article Single-Domain Antibodies for Brain Targeting
Site-specific conjugation of a Fab fragment to serum albumin by maleimide crosslinking or generation of a bispecific Fab with specificity for serum albumin in one arm increased half life in rats (27).…

Previous Page